Inhibition by acetylcholine of adrenergic neurotransmission in vascular smooth muscle.
D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001808:Blood Vessels / Q000294:innervation*; D004285:Dogs; D004558:Electric Stimulation; D005263:Femoral Artery / Q000294:innervation; D005268:Femoral Vein / Q000294:innervation; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008638:Mesenteric Arteries / Q000294:innervation; D008642:Mesenteric Veins / Q000294:innervation; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000294:innervation*; D009638:Norepinephrine / Q000378:metabolism; D011651:Pulmonary Artery / Q000294:innervation; D011667:Pulmonary Veins / Q000294:innervation; D012501:Saphenous Vein / Q000294:innervation; D009435:Synaptic Transmission / Q000187:drug effects*; D013779:Tetrodotoxin / Q000494:pharmacology; D013977:Tibia / Q000098:blood supply; D014316:Tritium; D014666:Vasomotor System / Q000187:drug effects*
D014316:Tritium; D013779:Tetrodotoxin; D001285:Atropine; D007545:Isoproterenol; D000109:Acetylcholine; D009638:Norepinephrine